These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 37755647)
1. Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors. He R; Weng Z; Liu Y; Li B; Wang W; Meng W; Li B; Li L Stem Cell Rev Rep; 2023 Nov; 19(8):2557-2575. PubMed ID: 37755647 [TBL] [Abstract][Full Text] [Related]
2. Cancer cells as a new source of induced pluripotent stem cells. Shamsian A; Sahebnasagh R; Norouzy A; Hussein SH; Ghahremani MH; Azizi Z Stem Cell Res Ther; 2022 Sep; 13(1):459. PubMed ID: 36064437 [TBL] [Abstract][Full Text] [Related]
13. p53 switches off pluripotency on differentiation. Lin T; Lin Y Stem Cell Res Ther; 2017 Feb; 8(1):44. PubMed ID: 28241890 [TBL] [Abstract][Full Text] [Related]
14. Current status in cancer cell reprogramming and its clinical implications. Izgi K; Canatan H; Iskender B J Cancer Res Clin Oncol; 2017 Mar; 143(3):371-383. PubMed ID: 27620745 [TBL] [Abstract][Full Text] [Related]
15. [Application of iPSC technology to cancer treatment]. Oshima N; Aoi T Gan To Kagaku Ryoho; 2015 Feb; 42(2):139-43. PubMed ID: 25743131 [TBL] [Abstract][Full Text] [Related]
20. A real-time pluripotency reporter for the long-term and real-time monitoring of pluripotency changes in induced pluripotent stem cells. Shen HF; Li YL; Huang SH; Xia JW; Yao ZF; Xiao GF; Zhou Y; Li YC; Shi JW; Lin XL; Zhao WT; Sun Y; Tian YG; Jia JS; Xiao D Aging (Albany NY); 2022 May; 14(10):4445-4458. PubMed ID: 35575836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]